Inhaled fentanyl for cancer patients
Treatments studied
Part of Cancer clinical trials.
This study tests an inhaled fentanyl spray for pain relief in Chinese adults with solid tumors. You may join if you have stable blood counts and organ function, and have not used strong painkillers recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You have a cancer diagnosis confirmed by biopsy or cell sample.
- Your body mass index (BMI) is between 21 and 30.
- Your blood counts and liver/kidney function are within certain limits (checked by blood tests).
- You have not used opioid pain medicines like morphine or fentanyl in the last 14 days.
- You are not allergic to opioids and have no severe lung disease like asthma or COPD.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at fatigue in Chinese cancer patients to understand how common it is and how it affects their health. You may join if you have a confirmed cancer diagnosis and are at least 18 years old.
This trial tests a new experimental drug (called NCP-IL-22BP mRNA) for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe, tolerable, and maybe effective against the cancer.
This study tests a new imaging dye (called a probe) that targets a specific change in lung cancer cells (EGFR mutation). The PET/CT scan uses this dye to see if the tumor can be clearly seen, which might help doctors plan better treatment.
This trial tests a new injection called sss40 to treat moderate-to-severe pain caused by cancer that has spread to the bones. The goal is to see if it is safe and effective for people whose pain is not being controlled by current treatments.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
This study tests an experimental drug (LNF1901) for people with advanced cancers that haven't responded to standard treatments. The goal is to see if it is safe and how well it works, and it might help control the cancer or shrink tumors.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.